Patrick, G N

p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. [electronic resource] - The Journal of biological chemistry Sep 1998 - 24057-64 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0021-9258

10.1074/jbc.273.37.24057 doi


Acetylcysteine--analogs & derivatives
Animals
COS Cells
Cells, Cultured
Cerebral Cortex--metabolism
Cyclin-Dependent Kinase 5
Cyclin-Dependent Kinases
Cysteine Endopeptidases--metabolism
Embryo, Mammalian
Enzyme Activation
Enzyme Inhibitors--pharmacology
Half-Life
Humans
Kinetics
Mammals
Mice
Multienzyme Complexes--metabolism
Nerve Tissue Proteins--genetics
Neurons--cytology
Polymerase Chain Reaction
Proteasome Endopeptidase Complex
Protein Serine-Threonine Kinases--antagonists & inhibitors
Purines--pharmacology
Rats
Rats, Sprague-Dawley
Recombinant Proteins--metabolism
Roscovitine
Sequence Deletion
Transfection
Ubiquitins--metabolism